| Literature DB >> 31516996 |
Patricia Richey1, Melia Holt1, Sydney Crotts1, Ali Jabbari1,2,3.
Abstract
Entities:
Keywords: DEB, dystrophic epidermolysis bullosa; EB, epidermolysis bullosa; PCR, polymerase chain reaction; PEB, pretibial epidermolysis bullosa; RNA splicing; epidermolysis bullosa; exon skipping; lower extremity ulcers
Year: 2019 PMID: 31516996 PMCID: PMC6728729 DOI: 10.1016/j.jdcr.2019.06.032
Source DB: PubMed Journal: JAAD Case Rep ISSN: 2352-5126
Fig 1Clinical presentation. Physical examination found well-circumscribed violaceous plaques of varying sizes in the pretibial region (A) as well as on the posterior legs (B and C). Milia (A), ulceration (B), and tense bullae were noted (C).
Fig 2Dominant mutation causing exon skipping in COL7A1. A, Our patient's mutation, a c.7984-2delA splice site mutation, putatively affects pre-mRNA splicing, leading to skipping of exon 108 within collagenous domain 1 of procollagen VII. Depicted is the genomic DNA (center) with exons illustrated as boxes with intervening introns illustrated as a solid black line. A red X marks the expected variation site for our patient. The expected mRNA is depicted as labeled for wild type (top) and for mRNA with a skipped exon 108 (bottom). PCR amplification products (dotted lines) are shown with the primers that were used (black boxes); resulting product lengths are labeled. B, Products of indicated PCR reaction are shown. Lane numbers correspond to DNA ladder with white arrowheads indicating ladder band length size (1), no template PCR reaction (2), healthy control/wild-type genomic template (3), and PEB patient genome template (4). Blue arrowhead is shown at approximately 251 base pairs, where wild-type template product is expected. Red arrowhead is shown at approximately 188 base pairs, where exon108-skipped template product is expected.